Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression (Q39223818)
Jump to navigation
Jump to search
scientific article published on 18 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression |
scientific article published on 18 December 2012 |
Statements
1 reference
Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression (English)
1 reference
Ling-Hua Zhang
1 reference
Jolanta Kosek
1 reference
Maria Wang
1 reference
Carla Heise
1 reference
Peter H Schafer
1 reference
Rajesh Chopra
1 reference
18 December 2012
1 reference
1 reference
Identifiers
1 reference